Upcoming Login Downtime

We're updating the Biocentury.com platform login experience to make access more secure and reliable. As part of this update, logins will be temporarily unavailable on Sunday, March 16, from 4:00AM to 4:00PM GMT. We recognize the inconvenience and appreciate your understanding. Please check back after the maintenance period.

For updates, questions, or issues, please call us at +1 650-552-4224 or email us at support@biocentury.com.

BioCentury
ARTICLE | Management Tracks

Sam Raha named COO at Myriad

Plus: Endeavor hires a new CMO, and updates from Jasper, Syantra, Ocuphire, Senisca and more

November 2, 2023 11:28 PM UTC

Genetic testing company Myriad Genetics Inc. (NASDAQ:MYGN) hired Sam Raha as COO, effective Dec.11. Raha was president of the diagnostics and genomics group at Agilent Technologies Inc. (NYSE:A), and previously served as VP of global marketing at Illumina Inc. (NASDAQ:ILMN).

Fibrotic and cancer disease company Endeavor BioMedicines Inc. hired Paul Frohna as CMO. Frohna was CMO and head of R&D at ImCheck Therapeutics S.A.S., before which he was CMO at Bioniz Therapeutics Inc...

Get Unlimited Access
Continue reading with a free trial.
Or Purchase This Article